中智药业品牌怎么样 申请店铺

我要投票 中智药业在医疗器械行业中的票数:697 更新时间:2026-02-04
中智药业是哪个国家的品牌?「中智药业」是 中山市中智药业集团有限公司 旗下著名品牌。该品牌发源于广东省中山市,在1993年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力中智药业品牌出海!将品牌入驻外推网,定制中智药业品牌推广信息,可以显著提高中智药业产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

中智药业怎么样

创办于1993年,拥有中智制药/恒生药业/中智中药饮片/中智大药房连锁等子公司,集中成药/中药饮片/保健品科研/生产与销售为一体


中智药业集团创办于1993年,集中成药、中药饮片、保健品科研、生产与销售为一体,拥有中智制药、恒生药业、中智中药饮片、中智大药房连锁四家子公司,拥有多个中药GAP种植研发基地和工程技术中心,药品生产经营产业链完善。

中智药业集团现有两大高科技生产基地,科研、生产能力和后续发展能力极强,拥有颗粒、胶囊、片剂、茶剂、口服液等剂型。目前,集团公司共有以“克咳片”为核心的中成药品种70多个,其中,包括有“石岐外感颗粒”、“小儿七星茶口服液”等品种7个,以及国家中药保护品种“金鸡颗粒”、“金鸡片”2个,全部医保品种16个。以第四代中药饮片——中药超微粉体为基础再创新升级的科技产品——破壁粉粒系列,是中智的科技品牌产品,拥有多项自主知识产权。以破壁粉粒产品为代表的“创新中药”系列产品,包括配方饮片、广东凉茶、药膳汤料、袋泡茶系列共有品种100多个。

中智药业集团紧跟国家中医药产业发展的方针政策,不遗余力的推进企业“精粹国药旗舰工程”的建设,依托生产、销售、营销服务和品牌打造等优势,企业正步上高科技发展之路。


Founded in 1993, it has subsidiaries such as China intelligent pharmaceutical / Hengsheng pharmaceutical / China intelligent Chinese Herbal Pieces / China intelligent pharmacy chain, and China intelligent Pharmaceutical Group is founded in 1993, integrating research, production and sales of ready-made medicine / Chinese Herbal Pieces / health care products, and integrating research, production and sales of ready-made medicine, Chinese herbal pieces, and health care products. It has China intelligent pharmaceutical, Hengsheng pharmaceutical, China intelligent Chinese herbal pieces, and China intelligent The pharmacy chain has four subsidiaries, multiple gap planting R & D bases and engineering technology centers for traditional Chinese medicine, and a complete pharmaceutical production and operation industry chain. At present, CIIC Pharmaceutical Group has two high-tech production bases with strong scientific research, production capacity and follow-up development capacity. It has such dosage forms as granules, capsules, tablets, tea agents and oral liquids. At present, the group has more than 70 varieties of Chinese patent medicine with Keke tablet as the core, including 7 varieties such as Shiqi waigan granule, xiaoerqixing tea oral liquid, 2 National Traditional Chinese medicine protection varieties such as Jinji granule and Jinji tablet, and 16 medical insurance varieties. Based on the fourth generation of decoction pieces of traditional Chinese Medicine - ultra micro powder of traditional Chinese medicine, the new and upgraded technology product - broken wall powder series, is a technology brand product of CIIC, with a number of independent intellectual property rights. There are more than 100 series of "innovative traditional Chinese medicine" products represented by broken wall powder and granule products, including formula pieces, Guangdong herbal tea, medicated diet soup and tea bag series. CIIC Pharmaceutical Group keeps up with the national policies and guidelines for the development of traditional Chinese medicine industry, spare no effort to promote the construction of the enterprise's "national medicine flagship project". Relying on the advantages of production, sales, marketing services and brand building, the enterprise is on the road of high-tech development.

本文链接: https://brand.waitui.com/dc1334ec1.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

瑞银:存储芯片2028年才有可能出现有意义的供给缓解

瑞银分析师团队表示,短期可聚焦于两大堪称垄断的HDD霸主——即希捷与西部数据公司,可把它们共同当作“存储景气度周期类型短期交易主题”,中长期把超额收益押在Memory(HBM、高端DDR、以及数据中心企业级SSD背后的NAND/控制器生态)的供需缺口与定价权上——这与当前AI数据中心扩张正在把HBM与传统DRAM/NAND推向更强烈的供需失衡相一致,也就是说三大存储芯片原厂主导的定价与供给纪律只会导致供需愈发失衡,且2028年才有可能出现有意义的供给缓解。(财联社)

2小时前

奈飞联席CEO就收购华纳兄弟交易遭美国参议院委员会质询

奈飞联席首席执行官泰德・萨兰多斯于周二出席美国参议院听证会,就公司拟以827亿美元收购华纳兄弟探索公司的交易接受质询,听证会核心聚焦该交易对流媒体娱乐行业竞争格局的影响。美国司法部正对这宗交易展开审查,与此同时,派拉蒙 - 天舞传媒也向华纳兄弟提出了竞争性的敌意收购要约。(新浪财经)

2小时前

惠普任命临时首席执行官

惠普2月3日宣布任命Bruce Broussard为临时首席执行官,即刻生效,他将接替Enrique Lores的职务,后者已辞去总裁兼首席执行官及董事会成员职务,以追求新的职业发展机会。(界面)

2小时前

美股大型科技股盘前普涨,英特尔涨超3%

36氪获悉,美股大型科技股盘前普涨,截至发稿,英特尔涨超3%,谷歌、特斯拉涨超1%,亚马逊涨0.9%,英伟达涨0.77%,微软涨0.34%,Meta涨0.23%,苹果跌0.62%。

2小时前

热门中概股美股盘前涨跌不一,阿里巴巴跌超2%

36氪获悉,热门中概股美股盘前涨跌不一,截至发稿,阿里巴巴、百度、哔哩哔哩跌超2%,京东、网易跌超1%,小鹏汽车涨超2%,拼多多、蔚来涨超1%,理想汽车涨0.6%。

2小时前

本页详细列出关于中智药业的品牌信息,含品牌所属公司介绍,中智药业所处行业的品牌地位及优势。
咨询